S100A12 and Sepsis: Previous studies have demonstrated that S100A12 enhances the expression of adhesion factors and induces the activation of human monocytes via Toll-like receptor 4, thereby acting as an enhancer of innate immunity in the early stages of inflammation and sepsis [17, 29, 31, 37].